ASML Stock Analysis: ASML Holding New York | NASDAQ
Semiconductor Equipment & Materials | NASDAQ, USA | Market Cap: 549.124m USD | 12M Return: 45.2% | USN070592100 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 2.54B
EPS Trend: 90.2%
Qual. Beats: 3
Rev. Trend: 94.1%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
ASML Holding N.V., headquartered in Veldhoven, the Netherlands, is a leading supplier of lithography systems and related equipment used by semiconductor manufacturers. The companys core products span extreme ultraviolet (EUV) and deep ultraviolet (DUV) lithography systems (including immersion and dry systems), as well as metrology and inspection tools such as the YieldStar optical metrology platform and electron beam defect analysis systems. It also provides computational lithography software, lithography system controls, refurbishment and upgrade offerings, and ongoing customer support services, effectively delivering an integrated hardware, software, and services package to chipmakers.
The company operates globally, serving customers across Asia (Japan, South Korea, Singapore, Taiwan, China, and other Asian markets), Europe (including the Netherlands), the Middle East, Africa, and the United States. Founded in 1984 and formerly known as ASM Lithography Holding N.V., ASML has been publicly traded since 1995 and is classified within the Semiconductor Materials & Equipment sub-industry. Lithography systems such as those ASML produces are a critical, capital-intensive step in wafer fabrication, and EUV systems in particular are sold in low volumes to a small number of leading-edge foundries and memory producers, contributing to the companys concentrated customer base and high barriers to entry in the segment.
- AI chip demand accelerates advanced node EUV system orders
- Netherlands export restrictions cap China lithography revenue
- High-NA EUV adoption lifts gross margin and revenue mix
| Net Income: 13.5b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.36 > 0.02 and ΔFCF/TA 15.97 > 1.0 |
| NWC/Revenue: 30.71% < 20% (prev 18.38%; Δ 12.33% < -1%) |
| CFO/TA 0.39 > 3% & CFO 22.7b > Net Income 13.5b |
| Net Debt (-10.8b) to EBITDA (16.4b): -0.66 < 3 |
| Current Ratio: 1.49 > 1.5 & < 3 |
| Outstanding Shares: last quarter (383.5m) vs 12m ago -1.06% < -2% |
| Gross Margin: 54.34% > 18% (prev 52.71%; Δ 1.63% > 0.5%) |
| Asset Turnover: 75.85% > 50% (prev 71.43%; Δ 4.43% > 0%) |
| Interest Coverage Ratio: 130.0 > 6 (EBIT TTM 15.4b / Interest Expense TTM 118.3m) |
| A: 0.21 (Total Current Assets 37.0b - Total Current Liabilities 24.9b) / Total Assets 59.0b |
| B: 0.30 (Retained Earnings 17.6b / Total Assets 59.0b) |
| C: 0.30 (EBIT TTM 15.4b / Avg Total Assets 52.0b) |
| D: 0.60 (Book Value of Equity 22.1b / Total Liabilities 36.9b) |
| Altman-Z'' = 4.93 = AAA |
| DSRI: 1.32 (Receivables 10.8b/6.68b, Revenue 39.5b/32.2b) |
| GMI: 0.97 (GM 52.71% / 54.34%) |
| AQI: 0.87 (AQ_t 0.23 / AQ_t-1 0.26) |
| SGI: 1.23 (Revenue 39.5b / 32.2b) |
| TATA: -0.16 (NI 13.5b - CFO 22.7b) / TA 59.0b) |
| Beneish M = -2.72 (Cap -4..+1) = A |
As of November 13, 2026, the stock is trading at USD 1497.12 with a total of 1,827,870 shares traded. Over the past week, the price has changed by +10.35%, over one month by -14.35%, over three months by -17.18% and over the past year by +45.21%.
Current recommended Stop Loss: 1334.00 (which is 10.9% or 2.4 ATR below the current price).
ASML Holding New York has received a consensus analysts rating of 4.63. Therefore, it is recommended to buy ASML.
- StrongBuy: 31
- Buy: 7
- Hold: 2
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 2137.3 | 42.8% |
Market Cap EUR = 495b (549b USD * 0.90079998970032 USD.EUR)
P/E Trailing = 35.0578
P/E Forward = 21.645
P/S = 13.9112
P/B = 22.1531
P/EG = 0.7428
Revenue TTM = 39.5b EUR
EBIT TTM = 15.4b EUR
EBITDA TTM = 16.4b EUR
Long Term Debt = 1.96b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.68b EUR (from shortTermDebt, last fiscal year)
Debt = 1.96b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -10.8b EUR (calculated: Debt 1.96b - CCE 12.7b)
Enterprise Value = 484b EUR (495b + Debt 1.96b - CCE 12.7b)
Interest Coverage Ratio = 130.0 (Ebit TTM 15.4b / Interest Expense TTM 118.3m)
EV/FCF = 22.89x (Enterprise Value 484b / FCF TTM 21.1b)
FCF Yield = 4.37% (FCF TTM 21.1b / Enterprise Value 484b)
FCF Margin = 53.56% (FCF TTM 21.1b / Revenue TTM 39.5b)
Net Margin = 34.14% (Net Income TTM 13.5b / Revenue TTM 39.5b)
Gross Margin = 54.34% ((Revenue TTM 39.5b - Cost of Revenue TTM 18.0b) / Revenue TTM)
Gross Margin QoQ = 57.45% (prev 53.99%)
Tobins Q-Ratio = 8.20 (Enterprise Value 484b / Total Assets 59.0b)
Interest Expense / Debt = 6.03% (Interest Expense 118.3m / Debt 1.96b)
Taxrate = 16.69% (2.70b / 16.2b)
NOPAT = 12.8b (EBIT 15.4b * (1 - 16.69%))
Current Ratio = 1.49 (Total Current Assets 37.0b / Total Current Liabilities 24.9b)
Debt / Equity = 0.09 (Debt 1.96b / totalStockholderEquity, last quarter 22.1b)
Debt / EBITDA = -0.66 (Net Debt -10.8b / EBITDA 16.4b)
Debt / FCF = -0.51 (Net Debt -10.8b / FCF TTM 21.1b)
Total Stockholder Equity = 21.1b (last 4 quarters mean from totalStockholderEquity)
RoA = 25.89% (Net Income 13.5b / Total Assets 59.0b)
RoE = 63.91% (Net Income TTM 13.5b / Total Stockholder Equity 21.1b)
RoCE = 66.71% (EBIT 15.4b / Capital Employed (Equity 21.1b + L.T.Debt 1.96b))
RoIC = 37.91% (NOPAT 12.8b / Invested Capital 33.8b)
WACC = 10.97% (E(495b)/V(497b) * Re(10.99%) + D(1.96b)/V(497b) * Rd(6.03%) * (1-Tc(0.17)))
Discount Rate = 10.99% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -96.95 | Cagr: -1.14%
[DCF] Terminal Value 69.99% ; FCFF base≈16.3b ; Y1≈18.7b ; Y5≈27.5b
[DCF] Fair Price = 760.2 (EV 282b - Net Debt -10.8b = Equity 293b / Shares 385.4m; r=10.97% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 90.25 | EPS CAGR: 26.34% | SUE: 4.0 | # QB: 3
Revenue Correlation: 94.12 | Revenue CAGR: 15.30% | SUE: -0.21 | # QB: 0
EPS current Quarter (2027-03-31): EPS=12.94 | Chg30d=+7.05% | Revisions=+50% | Analysts=8
EPS current Year (2026-12-31): EPS=41.41 | Chg30d=+8.01% | Revisions=+86% | GrowthEPS=+67.6% | GrowthRev=+36.2%
EPS next Year (2027-12-31): EPS=56.43 | Chg30d=+9.09% | Revisions=+88% | GrowthEPS=+36.3% | GrowthRev=+29.0%
[Analyst] Revisions Ratio: +90% (up=46, down=1)